Survival outcomes of Zo-NAnTAx: a five-year analysis of zoledronic acid added to a neoadjuvant regimen for HER2-positive breast cancer
@article{ATM123168, author = {Bruno de Paula and Eliana Abdelhay and Carlos Augusto Moreira de Sousa and Susanne Crocamo}, title = {Survival outcomes of Zo-NAnTAx: a five-year analysis of zoledronic acid added to a neoadjuvant regimen for HER2-positive breast cancer}, journal = {Annals of Translational Medicine}, volume = {12}, number = {3}, year = {2024}, keywords = {}, abstract = {}, issn = {2305-5847}, url = {https://atm.amegroups.org/article/view/123168} }